Skip to main content
FinSpry Logo
FinSpry
CATX logo
CATX
(NYSEAMERICAN)
Perspective Therapeutics, Inc.
$3.77-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Perspective Therapeutics (CATX) Stock Price & Financial Analysis

Perspective Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.68 - $3.87
52-Week High$6.16
52-Week Low$1.96
Open$3.82
Volume1.11M
Average Volume (3M)1.37M
Market Cap267.94M
Shares Outstanding73.81M
Price to Sales (P/S)318.60
Price to Book (P/B)1.29
EV/EBITDA-2.20
Revenue (TTM)841.00K
Net Income (TTM)-103.12M
Free Cash Flow (TTM)-95.23M
EPS (TTM)$-1.40
Profit Margin-12261.71%
Operating Margin-13503.45%
Return on Equity (ROE)-49.81%
Debt to Equity0.01
50-Day MA$4.43
200-Day MA$3.62
52-Week Change54.58%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Perspective Therapeutics

What is the current stock price for CATX?

As of the latest trading session, CATX stock trades at $3.76. The 52-week range is $1.96–$6.16, with a day range of $3.68–$3.87.

What is the P/E ratio for CATX?

The P/E ratio (Price-to-Earnings) for CATX is shown in the Key Statistics section. This valuation metric helps compare Perspective Therapeutics, Inc. to industry peers.

Does CATX pay dividends?

Perspective Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CATX?

Based on 9 analysts, the consensus for CATX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CATX?

Perspective Therapeutics's market capitalization is $277.5M, classifying it as a micro-cap company. Perspective Therapeutics operates in the Healthcare sector within the Medical Devices industry.